These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis. Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337 [TBL] [Abstract][Full Text] [Related]
4. [Demodicidosis in a female patient treated as allergic blepharoconjunctivitis. A case report]. Morfin Maciel BM Rev Alerg Mex; 2003; 50(6):232-6. PubMed ID: 14968988 [TBL] [Abstract][Full Text] [Related]
5. [. Oсumethyl in the treatment of allergic diseases of eyelids and conjunctiva]. Marchenko NR Vestn Oftalmol; 2016; 132(5):81-85. PubMed ID: 27911431 [TBL] [Abstract][Full Text] [Related]
6. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR; Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481 [TBL] [Abstract][Full Text] [Related]
7. [Eye lid hygiene in chronic allergic blepharoconjunctivitis patients before laser refractive surgery]. Yanchenko SV; Malyshev AV; Sakhnov SN; Fedotova NV; Orekhova OY Vestn Oftalmol; 2016; 132(5):86-92. PubMed ID: 27911432 [TBL] [Abstract][Full Text] [Related]
8. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Virtanen HM; Reitamo S; Kari M; Kari O Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503 [TBL] [Abstract][Full Text] [Related]
9. [Topical administration of metronidazole gel as an effective therapy alternative in chronic Demodex blepharitis--a case report]. Junk AK; Lukacs A; Kampik A Klin Monbl Augenheilkd; 1998 Jul; 213(1):48-50. PubMed ID: 9743939 [TBL] [Abstract][Full Text] [Related]
10. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis. Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR; J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Leonardi A; Zafirakis P Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
13. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital. Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377 [TBL] [Abstract][Full Text] [Related]
14. Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis. Macejko TT; Bergmann MT; Williams JI; Gow JA; Gomes PJ; McNamara TR; Abelson MB; Am J Ophthalmol; 2010 Jul; 150(1):122-127.e5. PubMed ID: 20488431 [TBL] [Abstract][Full Text] [Related]
15. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions. Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655 [TBL] [Abstract][Full Text] [Related]
17. [Blepharitis. Demodex folliculorum, associated pathogen spectrum and specific therapy]. Demmler M; de Kaspar HM; Möhring C; Klauss V Ophthalmologe; 1997 Mar; 94(3):191-6. PubMed ID: 9181834 [TBL] [Abstract][Full Text] [Related]
18. Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis. Liang L; Safran S; Gao Y; Sheha H; Raju VK; Tseng SC Cornea; 2010 Dec; 29(12):1386-91. PubMed ID: 20847679 [TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment. Sakarya Y; Sakarya R J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968 [TBL] [Abstract][Full Text] [Related]
20. [The use of the medicine Ophtalmoferon for the treatment of conjunctivitis in patients with HIV-infection and tuberculosis]. Mordyk AV; Bagisheva NV; Nebesnaya EY; Khlebova NV; Sitnikova SV; Nesterova KI; Trukhan DI; Moiseeva MV Vestn Oftalmol; 2021; 137(4):82-89. PubMed ID: 34410061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]